セッション情報

プレナリーセッション

第51回・2013年・京都
プレナリーセッション
プレナリーセッション02
乳腺
開催回
第51回・2013年・京都

Ph III BOLERO-2 study of everolimus plus exemestane: Japanese subgroup analysis

演題番号 : PS2-2

Norikazu Masuda:1、Yoshinori Ito:2、Hiroji Iwata:3、Hirofumi Mukai:4、Jun Horiguchi:5、Yutaka Tokuda:6、Katsumasa Kuroi:7、Tarek Sahmoud:8、Nobutsugu Ohno:9、Shinzaburo Noguchi:10

1:Department of Surgery, Breast Oncology, National Hospital Organization, Osaka National Hospital, Japan、2:Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital of JFCR, Japan、3:Department of Breast Oncology, Aichi Cancer Center Hospital, Japan、4:Divisions of Oncology/Hematology, National Cancer Center Hospital East, Japan、5:Department of Thoracic and Visceral Organ Surgery, Gunma University Hospital, Japan、6:Department of Breast and Endocrine Surgery, Tokai University Hospital, Japan、7:Division of Breast Surgery, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Japan、8:Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America、9:Novartis Pharma K.K., Japan、10:Department of Breast and Endocrine Surgery, Osaka University Hospital, Japan

Ph III BOLERO-2 study of everolimus plus exemestane: Japanese subgroup analysis